Zefei Jiang Selected Research

Zefei Jiang Research Topics

Disease

95	Breast Neoplasms (Breast Cancer) 03/2024 - 12/2000
35	Neoplasms (Cancer) 02/2024 - 09/2003
16	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2014
10	Neutropenia 01/2023 - 08/2012
9	Triple Negative Breast Neoplasms 01/2024 - 10/2014
9	Disease Progression 06/2023 - 11/2009
8	Diarrhea 03/2024 - 03/2010
5	Circulating Neoplastic Cells 07/2023 - 04/2013
4	Pathologic Complete Response 01/2023 - 01/2020
3	Hand-Foot Syndrome 01/2020 - 08/2012
2	Nausea 01/2023 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2021
2	Lymphatic Metastasis 05/2018 - 09/2014
2	Stomatitis 11/2017 - 07/2015
2	Exanthema (Rash) 11/2017 - 01/2017
2	Cardiotoxicity 12/2014 - 03/2010
1	Urinary Incontinence 01/2023
1	Vomiting 01/2023
1	Hemorrhage 01/2023
1	Hypokalemia 01/2023
1	Stroke (Strokes) 01/2023
1	Ductal Carcinoma 10/2021

Drug/Important Bio-Agent (IBA)

25	Trastuzumab (Herceptin)FDA Link 10/2023 - 11/2009
19	Hormones (Hormone)IBA 06/2023 - 01/2014
10	Estrogen ReceptorsIBA 12/2022 - 02/2007
9	AnthracyclinesIBA 10/2021 - 12/2010
8	human ERBB2 proteinIBA 10/2023 - 01/2019
8	ErbB Receptors (EGF Receptor)IBA 06/2023 - 03/2010
8	Capecitabine (Xeloda)FDA Link 01/2023 - 08/2012
8	Lapatinib (GW572016)FDA Link 01/2023 - 06/2013
7	Proteins (Proteins, Gene)FDA Link 07/2021 - 09/2003
6	Paclitaxel (Taxol)FDA LinkGeneric 11/2017 - 12/2010
5	pertuzumabIBA 03/2024 - 01/2019
5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
5	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 01/2022
5	taxaneIBA 01/2023 - 03/2012
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2013
5	Fulvestrant (Faslodex)FDA Link 11/2019 - 01/2011
4	exemestane (Aromasin)FDA Link 01/2023 - 12/2018
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 01/2017
4	Docetaxel (Taxotere)FDA Link 12/2022 - 08/2012
4	pyrotinibIBA 12/2022 - 10/2019
4	Gemcitabine FDA Link 12/2022 - 12/2010
4	Epidermal Growth Factor (EGF)IBA 01/2022 - 01/2017
4	Taxoids (Taxanes)IBA 10/2019 - 03/2012
3	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 07/2011
3	pegylated granulocyte colony-stimulating factorIBA 05/2020 - 05/2019
3	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2017
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 07/2014
3	Progesterone Receptors (Progesterone Receptor)IBA 05/2018 - 01/2014
2	Denosumab FDA Link 02/2024 - 06/2020
2	130-nm albumin-bound paclitaxelIBA 01/2024 - 12/2022
2	Tyrosine Kinase InhibitorsIBA 10/2023 - 03/2010
2	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2021
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2023 - 12/2018
2	Histone Deacetylase InhibitorsIBA 01/2023 - 12/2018
2	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2023 - 12/2018
2	N(4)-chloroacetylcytosine arabinoside (CACA)IBA 01/2022 - 10/2015
2	Transcription Factors (Transcription Factor)IBA 07/2021 - 02/2007
2	Diphosphonates (Bisphosphonates)IBA 06/2020 - 01/2017
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020 - 08/2012
2	apatinibIBA 01/2020 - 10/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2019 - 12/2000
2	Therapeutic UsesIBA 01/2019 - 11/2017
2	NVP-BKM120IBA 11/2018 - 01/2017
2	Everolimus FDA Link 11/2017 - 07/2015
2	Aromatase InhibitorsIBA 01/2017 - 12/2014
1	Biosimilar PharmaceuticalsIBA 02/2024
1	toripalimabIBA 01/2024
1	VaccinesIBA 12/2023
1	COVID-19 VaccinesIBA 12/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	palbociclibIBA 01/2023
1	abemaciclibIBA 01/2023
1	Tamoxifen FDA LinkGeneric 12/2022
1	PlatinumIBA 12/2022
1	margetuximabIBA 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Green Fluorescent ProteinsIBA 07/2021
1	RimonabantIBA 07/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2021
1	1,1-dimethyl-4-acetylpiperaziniumIBA 07/2021
1	Oncogene Proteins (Oncogene Protein)IBA 07/2021
1	Phosphotransferases (Kinase)IBA 07/2021

Therapy/Procedure

45	Therapeutics 06/2023 - 11/2009
30	Drug Therapy (Chemotherapy) 01/2024 - 11/2009
9	Neoadjuvant Therapy 06/2023 - 07/2014
5	Adjuvant Chemotherapy 06/2023 - 11/2009
3	Immunotherapy 01/2024 - 01/2023
3	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 12/2000
2	Radiotherapy 11/2022 - 01/2021
2	Segmental Mastectomy (Lumpectomy) 01/2022 - 01/2014
1	Electroacupuncture 01/2023
1	Palliative Care (Palliative Therapy) 12/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Precision Medicine 01/2022
1	Mastectomy (Mammectomy) 10/2021
1	Lymph Node Excision (Lymph Node Dissection) 10/2021